hematological parameters

Related by string. * Hematological : hematological cancers notably . hematological malignancies . non hematological toxicities . hematological toxicities . hematological malignancy . Hematological Malignancies / PARAMETERS . Parameters : metabolic parameters . physiological parameters . qualitative parameters . lipid parameters . pharmacodynamic parameters . hemodynamic parameters * *

Related by context. All words. (Click for frequent words.) 73 relapsed MM 73 Tasigna prolongs 72 serum phosphorous 72 SGPT 71 lactate dehydrogenase LDH 71 alanine aminotransferase 71 AST ALT 71 hMG 71 CTAP# Capsules 71 haematologic 71 aspartate aminotransferase AST 71 inducible nitric oxide synthase 71 hyperphenylalaninemia HPA due 70 pharmacodynamic parameters 70 β blockers 70 CYP#A# CYP#D# 70 PEGylated anti 70 BENICAR HCT 70 Microalbuminuria 70 aminotransferase 70 prospectively stratified 70 Posaconazole 70 epoetin alpha 70 TNFalpha 70 Cardiotoxicity 70 blood glucose lipids 70 oral antidiabetic medication 69 serum aminotransferase levels 69 serum lipid levels 69 lactate dehydrogenase 69 selective modulator 69 Pharmacokinetic parameters 69 echocardiographic parameters 69 MDS MPD 69 erythropoietic 69 plasma pharmacokinetics 69 CYT# potent vascular disrupting 69 HER2 expression 69 tryptase 69 APTIVUS r 69 K ras mutations 69 HER2 overexpression 69 Known hypersensitivity 69 serum PTH 69 interleukin IL -# 69 Patients Receiving 69 Warfarin Coumadin 69 aspirin clopidogrel 69 thyrotropin 69 myelodysplastic myeloproliferative diseases 69 metabolite concentrations 69 glycosylated hemoglobin HbA1c 69 elevated creatinine 69 TNF Tumor Necrosis Factor 69 FUSILEV enhances 69 Thiazolidinediones 69 Hepatotoxicity 69 parasitemia 69 ß blockers 68 Transplant Rejection 68 plasma lipids 68 hypocalcaemia 68 NMIBC 68 HES CEL 68 VP# [004] 68 Ribavirin causes 68 CYP#A# substrate 68 HMG CoA reductase inhibitors 68 See CLINICAL PHARMACOLOGY 68 systemic hypotension 68 glomerular filtration 68 elevated ALT 68 Creatinine 68 glycated hemoglobin levels 68 pharmacokinetic parameters 68 Adjuvant Treatment 68 novel VDA molecule 68 Interferon Beta 68 Mg Uk 68 HBeAg seroconversion 68 nicardipine 68 p# activation 68 R Saizen R 68 hepatic enzymes 68 Granulocyte Colony Stimulating Factor 68 Zorbtive TM 68 Pharmacokinetics PK 68 Antitumor Activity 68 myeloperoxidase 68 CIMZIA TM certolizumab pegol 68 metastatic neuroendocrine tumors 68 reactogenicity 68 calculated creatinine clearance 68 endometrial hyperplasia 68 lipid elevations 68 anaphylactic reactions bronchospasm 68 Proteinuria 68 headache abdominal pain 68 Demonstrated Significant 68 abacavir Ziagen 68 alfuzosin 68 alanine aminotransferase ALT 68 albumin excretion rate 68 intravascular hemolysis 68 induce orthostatic hypotension 68 ACTOplus met XR 68 Hypotension 67 liposomal amphotericin B 67 serum leptin 67 intact parathyroid hormone 67 Danazol 67 Lubiprostone 67 nitrotyrosine 67 aminotransferases 67 Endothelial dysfunction 67 WARNINGS Myopathy Rhabdomyolysis 67 sFlt 1 67 Kinoid 67 antibody titer 67 mutated K ras 67 receiving XGEVA 67 pathophysiological effects 67 Interferon beta 67 clevidipine 67 Allogeneic 67 bronchoalveolar lavage 67 Cystatin C 67 included exfoliative dermatitis 67 urinary N telopeptide 67 circulating endothelial cells 67 left ventricular diastolic 67 Estrogen Receptor 67 triglyceride concentrations 67 receiving VELCADE 67 BENICAR 67 Leydig cell 67 metaplasia 67 aspartate aminotransferase 67 unresectable tumors 67 dehydroepiandrosterone sulfate 67 hypomagnesemia 67 Mg Usa 67 SPRYCEL ® 67 LAB CGRP 67 serum triglycerides 67 Levels Linked 67 antiplatelet medications 67 lumbar spine BMD 67 Estradiol 67 endothelial activation 67 cervicitis 67 ABCB1 67 ritonavir boosted 67 hematologic parameters 67 prolonged QT interval 67 Hypercholesterolemia 67 cisplatin gemcitabine 67 serum lipid 67 TO AVOID PREGNANCY WHILE 67 radiosensitivity 67 serum BDNF 67 Hyperparathyroidism 67 activated partial thromboplastin 67 riociguat 67 colorectal adenoma 67 plasma lipid 67 Decitabine 67 torsade de pointes 67 Index CDAI 67 conventional DMARDs 67 immunomodulation 67 pharmacodynamic effects 67 vitamin B# folic acid 67 lumbar spine bone 67 antiandrogens 67 demonstrated clinically meaningful 67 Oral Fingolimod 67 amisulpride 67 hepatic function 67 Azacitidine 67 severe hypersensitivity reactions 67 lipid lowering agents 67 triiodothyronine 67 serum calcium levels 67 rFSH 67 saline placebo 67 pretransplant 67 thromboxane A2 67 HBeAg 67 leukocyte counts 67 metastatic malignant 67 Pegylated 67 Cyclooxygenase 2 67 Pharmacokinetic 67 SSc 67 ALT normalization 67 autoantibody levels 67 CYP#C# [002] 67 5alpha reductase 67 plasma folate 67 baseline serum creatinine 67 troponin T 66 HepG2 cells 66 CIMZIA ™ 66 serum concentrations 66 liver histology 66 neutropenia thrombocytopenia 66 certolizumab 66 transaminases 66 creatine kinase 66 Vildagliptin 66 hypereosinophilic syndrome 66 paricalcitol 66 hemoglobin Hb 66 STRIDE PD 66 tumor histology 66 CIMZIA R 66 isoenzyme 66 dose proportionality 66 PLX STROKE targeting 66 deep venous thromboses 66 mGluR5 NAM 66 artery stenosis 66 MULTAQ 66 interferon γ 66 transaminase elevations 66 cardiovascular calcification 66 TPMT 66 Naive Patients 66 serum phosphate 66 R lenalidomide 66 chronic eosinophilic leukemia 66 Serum concentrations 66 BARACLUDE ® 66 glycated hemoglobin HbA1c 66 anemia thrombocytopenia 66 oxycodone CR 66 Elevated serum 66 prednisone prednisolone plus 66 Atherosclerotic 66 histological subtype 66 TURBT 66 fosamprenavir 66 hypercalciuria 66 zoledronate 66 #.#mg/dL 66 carcinoembryonic antigen 66 Insulin sensitivity 66 phenothiazines 66 nitrofurantoin 66 MAGE A3 ASCI 66 serum potassium 66 F FDG PET 66 Hematologic 66 topically administered 66 Ischemic 66 Refractory Hodgkin Lymphoma 66 Hemodialysis Patients 66 thrombocytopenic 66 LH FSH 66 hemodynamic variables 66 Tumor Response 66 Oral corticosteroids 66 HIV HCV coinfected 66 apolipoprotein B 66 PBMCs 66 malignancy HCM 66 hA# 66 colorectal carcinoma 66 66 containing abacavir 66 Non inferiority 66 immunosuppressive regimen 66 posttransplant 66 ® lenalidomide 66 COPEGUS therapy 66 abacavir lamivudine 66 antitumor efficacy 66 Antitumor 66 #dhTxB# 66 specific antigen PSA 66 Natalizumab 66 Fasting glucose 66 Novel Inhibitor 66 somatostatin analog 66 urate oxidase 66 Orthostatic Hypotension 66 Thromboembolic 66 Cholinesterase Inhibitors 66 glucose insulin 66 INVEGA ® 66 serum cortisol 66 receptor blocker 66 Cardiopulmonary bypass 66 leukopenia pancytopenia thrombocytopenia 66 hypophosphatemia 66 QTc prolongation 66 reduce serum phosphate 66 homocysteine concentrations 66 galiximab 66 hepatic liver 66 adrenocorticotropic hormone 66 clomiphene citrate 66 Teriparatide 66 biochemical relapse 66 vWF 66 hypocalcemia 66 nonnucleoside reverse transcriptase inhibitors 66 H2 antagonists 66 unstable angina pectoris 66 Cardiorespiratory fitness 66 Drospirenone 66 Pharmacodynamics 66 baseline HbA1c 66 NIASPAN 66 neutropenia dehydration dyspnea 66 Shows Promise Against 66 antimetabolites 66 receptor tyrosine kinase inhibitor 66 inhibit platelet function 66 Initiate Clinical Trial 66 thalidomide Thalomid 66 Exacerbations 66 8mg/kg 66 creatinine ratio 66 leiomyomas 66 CLINICAL PHARMACOLOGY 66 Nebulized 66 Primary endpoints 66 EGFR HER2 66 HOMA IR 66 CIMZIA TM 66 clomipramine 66 Cotinine 66 ACTEMRA TM 66 recombinant FSH 66 cMET 66 pharmacodynamic PD 66 Androgens 66 AVAPRO 66 morphometric vertebral fractures 66 Plaquenil 66 umol L 66 candesartan cilexetil 66 glycaemia 66 tumor necrosis 66 C Reactive Protein 66 C telopeptide 66 Meets Primary Endpoint 66 sitosterol 66 demonstrated antitumor activity 66 overt nephropathy 66 baseline LDH 66 genotypic resistance 66 malondialdehyde MDA 66 Symptom severity 66 antiphospholipid antibodies 66 PRADAXA #mg 66 perioperatively 65 dose dependently 65 pharmacokinetic PK profile 65 intima media thickness 65 vasoactive 65 Nilotinib 65 protein tyrosine phosphatase 1B 65 transaminase levels 65 coadministration 65 bronchial hyperresponsiveness 65 PSA nadir 65 Demonstrates Positive 65 GnRH antagonist 65 SCr 65 affective psychosis 65 administered intramuscularly 65 nitroprusside 65 hepatic enzyme 65 ERalpha 65 transaminase 65 serum bicarbonate 65 EXJADE 65 glycosylated hemoglobin levels 65 ionotropic 65 Osteopontin 65 leukocyte count 65 eNO 65 lymphocyte counts 65 Carvedilol 65 hematopoietic cancers 65 transgene expression 65 posaconazole 65 SGOT 65 aminotransferase levels 65 Polymorphisms 65 dihydrofolate reductase 65 Hormone Refractory Prostate Cancer 65 HGPIN 65 hepatotoxic 65 flutamide 65 serum testosterone 65 Hp2 2 65 NPH insulin 65 IgG antibody 65 atrophic vaginitis 65 GAMMAGARD 65 elevated uric acid 65 thyroglobulin 65 serum urate levels 65 symptomatic VTE 65 Akt activation 65 Peginterferon alfa 2b 65 substantially excreted 65 nephrotoxicity 65 prostanoid 65 Histologic 65 isoprostane 65 Papillary 65 mesalamine granules 65 corticosteroid induced 65 intravesical therapy 65 Intracerebral 65 BYSTOLIC 65 platelet dysfunction 65 pharmacokinetic equivalence 65 vitreous floaters 65 diabetic kidney 65 EDARBI 65 allogeneic HSCT 65 Ki# 65 overt hypothyroidism 65 myopathy rhabdomyolysis 65 immunological responses 65 extramedullary 65 vasodilatation 65 neutropaenia 65 natriuretic peptides 65 N Acetyl 65 administered subcutaneously 65 ACE Inhibitors 65 mitoxantrone plus 65 fructosamine 65 BEXXAR Therapeutic Regimen 65 Pegloticase 65 coagulation abnormalities 65 bovine thrombin 65 Peginterferon Alfa 2a 65 virologic responses 65 Patients Treated With 65 Apolipoprotein B 65 ADCS CGIC 65 antiproliferative effects 65 DOSAGE AND ADMINISTRATION 65 hemoglobin A1c HbA1c 65 hepatoma 65 Chronic Renal Failure 65 mRNA expression 65 urothelial carcinoma 65 clinicopathological features 65 PSADT 65 Lymphoid 65 Plaque Psoriasis 65 stimulated insulin secretion 65 #mg/day [002] 65 hsCRP levels 65 urinary cortisol 65 leiomyoma 65 Cytotoxic T 65 pharmacokinetic characteristics 65 Hypokalemia 65 edifoligide 65 polycythemia vera essential thrombocythemia 65 glutamic acid decarboxylase 65 angiotensin II receptor blockers 65 μg liter 65 tricyclic antidepressants TCAs 65 insulin glulisine 65 Alequel 65 Aptivus ® 65 urinary calcium 65 serum albumin 65 Fasting blood glucose 65 elevated transaminases 65 LDL HDL 65 cardiac repolarization 65 plasma renin activity 65 colony stimulating factor 65 thromboembolic disease 65 Secondary endpoints included 65 plasma lipoprotein 65 weekly subcutaneous injections 65 steroid dexamethasone 65 Glucocorticoids 65 Demonstrate Significant 65 RAPAMUNE 65 neurodevelopmental outcome 65 acute humoral rejection 65 catheter occlusion 65 receptor inhibitor 65 salmeterol fluticasone 65 HBeAg negative 65 proton MR spectroscopy 65 urine albumin 65 protein excretion 65 poor metabolizers 65 haematopoietic 65 abdominal adiposity 65 moderate hepatic impairment 65 mediated inhibition 65 aPTT 65 thromboembolic complications 65 mg TID 65 clinicopathological 65 caspofungin 65 DAS# remission 65 nutlin 3a 65 HBsAg 65 Clusterin 65 RAS blockers 65 florbetaben 65 sitaxsentan 65 sargramostim 65 endothelin receptor antagonists 65 Sitagliptin 65 IMiDs ® 65 pulmonary artery banding 65 P#Y# [002] 65 Recombinant Human 65 gastric mucosa 65 elevated serum creatinine 65 Shows Statistically Significant 65 Dasatinib 65 Erythropoietic therapies may 65 Thalomid ® 65 griseofulvin 65 recombinant follicle stimulating 65 prolactin levels 65 Peginterferon 65 EtOH 65 Improves Outcomes 65 primidone 65 Androgen 65 macrolide antibiotic 65 CYP#D# inhibitor 65 sulphonylureas 65 tissue oxygenation 65 busulfan 65 serum lipids 65 Darinaparsin 65 LT NS# 65 estrogen metabolites 65 cytomegalovirus infection 65 lispro 65 triglycerides TG 65 Ocrelizumab 65 IL 1ß 65 benazepril 65 bronchoalveolar lavage fluid 65 decompensated liver disease 65 LPS induced 65 bacteriuria 65 Hyperuricemia 65 Fidaxomicin 65 NUCYNTA R 65 Interferon beta 1b 65 eosinophil count 65 Aurora Kinase 65 Teriflunomide 65 dosage regimens 65 selectively inhibited 65 Zoledronic acid 65 MP4OX 65 Comorbidities 65 oral prednisolone 65 paroxetine sertraline 65 oral hypoglycemic agents 65 serum estradiol 65 Pioglitazone 65 HIF 1a 65 MYCAMINE 65 pyrexia mucositis sepsis febrile 65 Secondary efficacy endpoints 65 ULORIC 65 monoamine oxidase inhibitors 65 serum creatinine levels 65 CONTRAINDICATIONS 65 symptomatic hyponatremia 65 hormone receptor status 65 primary hyperparathyroidism 65 ATACAND 65 Mycophenolate Mofetil 65 perioperative complications 65 Octreolin 65 del 5q MDS 65 rabeprazole 65 R# #mg BID 65 gastric adenocarcinoma 65 lipid parameters 65 Achieves Primary Endpoint 65 C1 Inhibitor 65 Hematocrit 64 REMINYL ® 64 antitumor effect 64 Generalized Anxiety Disorder 64 fosbretabulin 64 mucosal inflammation 64 cytotoxic effects 64 prostate carcinoma 64 Cathepsin B 64 Immunohistochemical staining 64 Atypical Hemolytic Uremic Syndrome 64 quetiapine Seroquel 64 serum TSH 64 Lp PLA 2 64 TMPRSS2 ERG 64 pyridostigmine 64 Lymphocytic 64 fasting insulin 64 thyroid peroxidase 64 risedronate Actonel 64 neutropenic patients 64 subcutaneous immunoglobulin 64 Selective serotonin reuptake inhibitors 64 N telopeptide 64 Retrograde ejaculation 64 postmenopausal osteoporotic women 64 cyclooxygenase COX 64 Bucindolol 64 RISPERDAL ® 64 urinary albumin excretion 64 Diabetic Neuropathy 64 bFGF 64 pioglitazone HCl 64 antidepressants fluoxetine 64 Plasma concentrations 64 Angiotensin converting enzyme 64 Transdermal Patch 64 lanreotide 64 headache nasopharyngitis 64 budesonide foam 64 NMDA antagonists 64 lanthanum carbonate 64 INVEGA ™ 64 immunoglobulin G 64 hyperinsulinemic euglycemic clamp 64 Prolactin 64 degranulation 64 fluconazole resistant 64 Atomoxetine 64 Leukemias 64 NQO1 64 mesangial 64 airway hyperresponsiveness 64 Thal Dex 64 budesonide pMDI 64 Demonstrates Efficacy 64 triacylglycerol concentrations 64 IOP lowering 64 oxcarbazepine 64 glulisine 64 bisoprolol 64 umbilical vein 64 Adenomas 64 pharmacodynamic markers 64 intracoronary 64 thrombocytosis 64 RRM1 64 Fracture Risk 64 SYN# 64 Long Term Efficacy 64 anticholinergic agents 64 TRAIL R1 64 receptor antagonism 64 fibrin deposition 64 Beta Amyloid 64 culture supernatants 64 tamoxifen Nolvadex ® 64 posttreatment 64 IM progesterone 64 Aldosterone 64 LymphoStat B belimumab 64 R Bortezomib 64 IgG4 64 Undesirable alterations 64 Viral load 64 Prostatic 64 selective agonists 64 INCB# [003] 64 ribavirin USP 64 G CSFs 64 -#.# mg dL [001] 64 Nonalcoholic Steatohepatitis 64 doxorubicin cyclophosphamide 64 renal toxicity 64 dopamine D2 64 orally administered inhibitor 64 apolipoprotein A1 64 pancreatic alpha 64 hsCRP 64 J Am Coll 64 alefacept 64 hyperammonemia 64 systemic corticosteroid 64 peginterferon alfa 64 lipoprotein Lp 64 epoetin beta 64 sUA 64 ALT flares 64 pentoxifylline 64 Severe hypersensitivity reactions 64 ara C 64 azilsartan medoxomil 64 dihydroergotamine 64 Acetate Rectal Suppositories 64 Cardiac Troponin 64 oral prodrug 64 TSH receptor 64 Epoetin Alfa 64 Postmenopausal 64 probiotic supplementation 64 antiangiogenic therapy 64 ovarian carcinoma 64 CSF biomarkers 64 pretreatment serum 64 Th1 type 64 Fondaparinux 64 Statistically Significant 64 GH deficiency 64 elevated fasting glucose 64 direct thrombin inhibitors 64 constitutively expressed 64 Calcitonin 64 mU liter 64 prostaglandin E 64 Novel Compound 64 renal cysts 64 estrone 64 Kidney Function 64 vidofludimus 64 CLINICAL STUDIES 64 histologic subtype 64 dysuria 64 elevated IOP 64 Methotrexate MTX 64 FOLFOX6 64 prescribed proton pump 64 achieved ACR# 64 Efficacious 64 Aeolus Pharmaceuticals Announces 64 fludarabine cyclophosphamide 64 exhaled nitric oxide 64 Non Responders 64 Capesaris 64 1mg 2mg 64 pulmonary arterial 64 MMP2 64 tumor lysis syndrome 64 cardiogenic 64 endoscopic remission 64 pharmacokinetic interactions 64 Histological 64 antiplatelet drugs 64 lesional 64 Controlled Trial 64 liver steatosis 64 titrated glipizide 64 CK MB 64 Immunoglobulin E 64 VELCADE melphalan 64 Hypertrophy 64 gene polymorphisms 64 LHRH receptor positive 64 refractory chronic lymphocytic 64 immunofluorescence microscopy 64 Soy isoflavones 64 Simulect 64 osteoblast 64 iPTH 64 vapreotide acetate 64 norethindrone acetate 64 atherogenic dyslipidemia 64 inflammatory biomarkers 64 vecuronium 64 platelet reactivity 64 Crohn Disease Activity 64 HLA DRB1 * 64 human chorionic gonadotropin hCG 64 myeloproliferative diseases 64 cefotaxime 64 Commonly prescribed 64 Ecallantide 64 oral hypoglycemic agent 64 EGFR tyrosine kinase inhibitor 64 β blocker 64 metabolic parameters 64 cytokines chemokines 64 drug eluting stent implantation 64 Hcy 64 peritoneal fluid 64 alkylating agent 64 Relapsing Multiple Sclerosis 64 deCODE AF TM 64 hepatorenal syndrome 64 Endothelial Function 64 tegaserod 64 deoxy 64 Hyperlipidemia 64 Relapsing Remitting Multiple Sclerosis 64 transdermal estradiol 64 total cholesterol triglycerides 64 GnRH agonist 64 IFN gamma 64 opioid naïve 64 thyroid stimulating hormone 64 Forodesine HCl 64 BoNTA 64 tipranavir r 64 Carbamazepine 64 anti JCV antibodies 64 Subgroup analyzes 64 colesevelam HCl 64 immunohistochemical 64 intestinal mucosal 64 abnormal clotting 64 microalbumin 64 acitretin 64 hemodilution 64 Pegylated Interferon 64 danazol 64 intestinal permeability 64 Bacteremia 64 nasopharyngitis headache 64 Retinoic Acid 64 heparanase 64 beta 1a 64 GRNCM1 64 nonhematologic adverse reactions 64 urinary excretion 64 IMiDs ® compound 64 Myoglobin 64 International Normalized Ratio 64 T2DM 64 glutamyl 64 spirometric 64 hepatic fibrosis 64 elevated prolactin 64 Vidaza azacitidine 64 tolterodine ER 64 Unstable angina 64 aldosterone antagonist 64 mcg BID 64 bacterial prostatitis 64 XP# Transported Prodrug 64 Fulvestrant 64 potassium sparing diuretics 64 maternal serum 64 Secondary endpoints 64 elevated LDH 64 Diffuse Large B 64 Univariate 64 unfractionated heparin UFH 64 warfarin erythromycin 64 pyrazinamide 64 Umbilical cord stem cells 64 Ileus 64 PCWP 64 glomerular 64 dalteparin 64 corifollitropin alfa 64 mTOR mammalian target 64 Transdermal Delivery 64 transrectal ultrasound guided 64 CYP#A# inhibitors 64 oral rivaroxaban 64 elevated triglyceride levels 64 airway hyper responsiveness 64 Hsp# Inhibitor 64 NOXAFIL Oral Suspension 64 impaired glucose metabolism 64 pharmacodynamic properties 64 VCAM 1 64 L lysine 64 Enzastaurin 64 blood glucose concentrations 64 hemodynamically significant 64 glucuronide 64 recombinant erythropoietin 64 plus octreotide LAR 64 amino acid metabolism 64 LOVENOX R 64 Tolerability 64 sustained virological response 64 platelet activation 64 LV dysfunction 64 sulfonylurea metformin 64 VKORC1 64 tigecycline 64 amprenavir 64 ADPKD 64 CG# [003] 64 Cimzia TM 64 Cleviprex TM clevidipine 64 denileukin diftitox 64 Gastrointestinal Stromal Tumors 64 Treg cell 64 kidney allograft 64 Double Blind Randomized 64 immunotoxicity 64 interleukin IL -6 64 CTAP# 64 mL/min/#.# m 2 64 CFTR inhibitors 64 AVANDIA 64 rHuEPO 64 BRAF V#E 64 hepatocellular 64 immunostaining 64 SIADH 64 INSPIRE Trial Phase III 64 pleiotropic effects 64 efavirenz EFV 64 TNF blocker therapy 64 liver transaminases 64 aplindore 64 omeprazole Prilosec 64 Ziprasidone 64 Fibrates 64 tumor xenograft models 64 serum glucose 64 serum prostate 64 non splenectomized 64 BCG refractory carcinoma 64 beta. 64 progressive dyspnea 64 bronchodilatory 64 Angiotensin receptor blockers 64 ACEIs 64 sitagliptin Januvia 64 Coadministration 64 hyperalgesia 64 nortriptyline Pamelor 64 HIV coinfected 64 E selectin 64 Endometrial 64 neuritic 64 μg kg 64 AGILECT R 64 urate lowering 64 biologic DMARD 64 Fibroblast 64 fasting plasma 64 angiographically 64 Hypertriglyceridemia 64 SUSTENNA TM 64 Gram stain 64 ramipril Altace 64 vWD 64 murine model 64 Hazard Ratio HR 64 adiponectin concentrations 64 Protease Inhibitors 64 sulfasalazine 64 PsA 64 Main Outcome Measure 64 Clinical Outcome 64 Daptomycin 64 #mg BID [003] 64 adrenocortical 64 ORENCIA R 64 AGTR1 64 basal bolus regimen 64 Primary Hypercholesterolemia 64 NovoLog ® Mix 64 serum CRP 64 retrograde ejaculation 64 Immunomodulatory 64 Alanine 64 hyaluronidase enzyme 64 Nesiritide 64 lowering blood glucose 64 unresectable HCC 64 differential gene expression 64 PDGFR 63 Pharmacokinetic studies 63 lenalidomide dexamethasone 63 Bioavailability 63 warfarin anticoagulation 63 prolactin elevation 63 squamous intraepithelial lesions 63 Metabolites 63 MENOPUR 63 Ozarelix 63 intima media thickness IMT 63 dermatologic reactions 63 thyroid hormone replacement 63 progression TTP 63 allogeneic hematopoietic stem cell 63 Adenoviral 63 albumin excretion 63 nucleoside analog 63 CD# + [001]

Back to home page